This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994; 79: 143–156.
Sun L, Liu A, Georgopoulos K . Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J 1996; 15: 5358–5369.
Cobb BS, Morales-Alcelay S, Kleiger G, Brown KE, Fisher AG, Smale ST . Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev 2000; 14: 2146–2160.
Papathanasiou P, Perkins AC, Cobb BS, Ferrini R, Sridharan R, Hoyne GF et al. Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor. Immunity 2003; 19: 131–144.
Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, Bigby M et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 1996; 5: 537–549.
Dumortier A, Jeannet R, Kirstetter P, Kleinmann E, Sellars M, dos Santos NR et al. Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice. Mol Cell Biol 2006; 26: 209–220.
Winandy S, Wu P, Georgopoulos K . A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 1995; 83: 289–299.
Mantha S, Ward M, McCafferty J, Herron A, Palomero T, Ferrando A et al. Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ mice. Leuk Res 2007; 31: 321–327.
Goldman FD, Gurel Z, Al-Zubeidi D, Fried AJ, Icardi M, Song C et al. Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene. Pediatr Blood Cancer 2011; 58: 591–597.
Kuehn HS, Boisson B, Cunningham-Rundles C, Reichenbach J, Stray-Pedersen A, Gelfand EW et al. Loss of B cells in patients with heterozygous mutations in IKAROS. N Engl J Med 2016; 374: 1032–1043.
Asai D, Imamura T, Suenobu S, Saito A, Hasegawa D, Deguchi T et al. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan. Cancer Med 2013; 2: 412–419.
Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269–271.
Witkowski MT, Cimmino L, Hu Y, Trimarchi T, Tagoh H, McKenzie MD et al. Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia. Leukemia 2015; 29: 1301–1311.
Popescu M, Gurel Z, Ronni T, Song C, Hung KY, Payne KJ et al. Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1. J Biol Chem 2009; 284: 13869–13880.
Song C, Pan X, Ge Z, Gowda C, Ding Y, Li H et al. Epigenetic regulation of gene expression by Ikaros, HDAC1 and casein kinase II in leukemia. Leukemia 2016; 30: 1436–1440.
Acknowledgements
We thank the patient and the family members for participating in this study. This work was supported by the Research on Measures for Intractable Diseases Project from Ministry of Health, Labor and Welfare, Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan (H23-TA012), Four Diamond Fund and the John Wawrynovic Leukemia Research Scholar Endowment.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Yoshida, N., Sakaguchi, H., Muramatsu, H. et al. Germline IKAROS mutation associated with primary immunodeficiency that progressed to T-cell acute lymphoblastic leukemia. Leukemia 31, 1221–1223 (2017). https://doi.org/10.1038/leu.2017.25
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2017.25
This article is cited by
-
IKAROS: from chromatin organization to transcriptional elongation control
Cell Death & Differentiation (2023)
-
Outcomes of CD19 chimeric antigen receptor T cell followed by haploidentical hematopoietic stem-cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukemia with IKZF1 deletion
Bone Marrow Transplantation (2022)
-
Advances in germline predisposition to acute leukaemias and myeloid neoplasms
Nature Reviews Cancer (2021)
-
A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS
Nature Immunology (2021)
-
Abnormal SCID Newborn Screening and Spontaneous Recovery Associated with a Novel Haploinsufficiency IKZF1 Mutation
Journal of Clinical Immunology (2021)